Wockhardt, Enso Health join hands for Sputnik jabs

New Delhi: Drug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its Covid-19 vaccine, to produce and supply Sputnik V and Sputnik Light.The contract is for manufacturing up to 620 million doses of Sputnik V and Sputnik Light by June 2023, the Mumbai-based drug maker said.

“According to the agreement, 70-120 million injection doses will be contract manufactured till June 30, 2022 which will be further extended to June 30, 2023 for a further 500 million doses. This is subject to certain conditions,’ it said.

In India, Hyderabad-based Dr Reddy’s Laboratories has been importing Russia-developed Sputnik V. RDIF, which is marketing the vaccine outside Russia, has deals with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech and Morepen in India for the production of more than 850 million doses per year. Supplies of India manufactured Sputnik are yet to begin.